Scoping Review of National Antimicrobial Stewardship Activities in Eight African Countries and Adaptable Recommendations.
CwPAMS
One Health
antibiotic resistance
national action plans
pharmacy
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
25 Aug 2022
25 Aug 2022
Historique:
received:
14
07
2022
revised:
15
08
2022
accepted:
17
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) is a global health problem threatening safe, effective healthcare delivery in all countries and settings. The ability of microorganisms to become resistant to the effects of antimicrobials is an inevitable evolutionary process. The misuse and overuse of antimicrobial agents have increased the importance of a global focus on antimicrobial stewardship (AMS). This review provides insight into the current AMS landscape and identifies contemporary actors and initiatives related to AMS projects in eight African countries (Ghana, Kenya, Malawi, Nigeria, Sierra Leone, Tanzania, Uganda, and Zambia), which form a network of countries participating in the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme. We focus on common themes across the eight countries, including the current status of AMR, infection prevention and control, AMR implementation strategies, AMS, antimicrobial surveillance, antimicrobial use, antimicrobial consumption surveillance, a one health approach, digital health, pre-service and in-service AMR and AMS training, access to and supply of medicines, and the impact of COVID-19. Recommendations suitable for adaptation are presented, including the development of a national AMS strategy and incorporation of AMS in pharmacists' and other healthcare professionals' curricula for pre-service and in-service training.
Identifiants
pubmed: 36139929
pii: antibiotics11091149
doi: 10.3390/antibiotics11091149
pmc: PMC9495160
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Antibiotics (Basel). 2020 Aug 29;9(9):
pubmed: 32872419
Int J Pharm Pract. 2016 Oct;24(5):358-66
pubmed: 26913925
Bull World Health Organ. 2017 Jul 01;95(7):503-516
pubmed: 28670015
PLoS One. 2021 Mar 9;16(3):e0248282
pubmed: 33690699
Pharmacy (Basel). 2020 Jun 24;8(2):
pubmed: 32599699
Wellcome Open Res. 2017 Sep 26;2:91
pubmed: 29181453
PLoS One. 2018 Nov 21;13(11):e0207465
pubmed: 30462700
Onderstepoort J Vet Res. 2015 Apr 16;82(1):816
pubmed: 26016985
PLoS One. 2020 Feb 10;15(2):e0228555
pubmed: 32040513
Trop Med Int Health. 2012 Apr;17(4):462-8
pubmed: 22413809
Antimicrob Resist Infect Control. 2020 Aug 28;9(1):145
pubmed: 32859252
Bull World Health Organ. 2020 Aug 01;98(8):530-538
pubmed: 32773898
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Antimicrob Resist Infect Control. 2020 Mar 3;9(1):37
pubmed: 32122406
Niger J Clin Pract. 2018 Nov;21(11):1476-1483
pubmed: 30417847
One Health. 2018 Nov 09;6:41-47
pubmed: 30533485
Antibiotics (Basel). 2021 Feb 09;10(2):
pubmed: 33572240
Epidemiol Infect. 2016 Nov;144(15):3288-3299
pubmed: 27334298
PLoS Med. 2013;10(3):e1001400
pubmed: 23554578
Fed Pract. 2018 Jan;35(1):24-31
pubmed: 30766319
PLoS One. 2019 Feb 12;14(2):e0212125
pubmed: 30753219
JMIR Form Res. 2018 Sep 24;2(2):e20
pubmed: 30684419
BMJ Glob Health. 2021 Nov;6(11):
pubmed: 34728479
Int J Infect Dis. 2020 Jan;90:71-76
pubmed: 31655112
Int J Infect Dis. 2020 Nov;100:123-131
pubmed: 32712427
Malawi Med J. 2019 Dec;31(4):225-232
pubmed: 32128032